Two more cancer drugs are in short supply, according to the FDA and the American Society of Health-System Pharmacists.
These drugs are the latest in a growing list of oncology medications in short supply:
Azacitidine injections: Three drugmakers stopped making 100 milligram solutions of the leukemia drug.
Iobenguane I-131 injections: Progenics Pharmaceuticals stopped making two solutions because of low demand for the oncology medication.